Neuralstem Inc. | Mutual Funds
Mutual Funds that own Neuralstem Inc.
Vanguard Total Stock Market Index Fund
341,528
2.25%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
165,532
1.09%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
67,699
0.45%
0
0%
07/31/2018
Vanguard Balanced Index Fund
13,509
0.09%
0
0%
07/31/2018
Pacific Select Fund - Small Cap Growth Portfolio
11,435
0.08%
0
0.01%
05/31/2018
Fidelity Spartan Total Market Index Fund
8,195
0.05%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
7,185
0.05%
0
0%
07/31/2018
3,975
0.03%
0
0.02%
09/05/2018
iShares Core S&P Total US Stock Market ETF
1,940
0.01%
0
0%
09/06/2018
AXA/Lord Abbett Micro Cap Portfolio
1,646
0.01%
0
0%
03/31/2018
| Address |
20271 Goldenrod Lane
Germantown Maryland 20876
United States
|
|
Employees
|
- |
| Website |
http://www.neuralstem.com |
| Updated |
07/08/2019 |
| Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. |
